ISSN 3105-6741(Print)
ISSN 3105-675X(Online)
往期阅览
版权信息

ISSN 3105-6741(Print)
ISSN 3105-675X(Online)
CODEN:LYYAA3
(国际标准连续出版物标识符·全球唯一标识符)
分配机构:美国化学文摘社(CAS)

编委会
主编

田明哲
同行评议专家

副主编
彭思妍  贺  颖  吕大传
曹  婷  文红琴  姜雨欣
曾浩宇  赖  萌  丁  妍
(以上排名不分先后顺序)
编委

编委会助理
施子辰
期刊主页
在线投稿
申请编委/副主编/同行评议专家
索引/检索/存档
DOI
EuroPub
欧洲学术出版中心数据库(英国)

Sci Online
研究者索引

欧亚科学期刊索引(ESJI)
武汉办事处
主任 库盛娟
电话 +86 027-8860 7188
邮箱 gjqk@qikan999.com
微信 qikan7188
地址 武汉市武昌东湖路181号
邮编 430077
Editing and Publishing
Macau Sino-Foreign Medical Publishing Limited(MSFMP)
Address
7th Floor,D, No.19,Palawak
Lane, Macau
Telephone
+853 6881 9699
Email
QuestPress@hotmail.com
Web site
http://lcyyyj.scionline2025.com

  首页 -> 往期阅览-> 2025年
《临床用药研究》( ISSN3105-6741、EISSN3105-675X ) 发布者:Quest Press 发布日期:2026/1/11
10.12479/questpress-lcyyyj.20250223 Open Access 下载0 浏览22

 

补阳还五汤辨证加减治疗继发性闭经的疗效观察

张晓晗
河南中医药大学第五临床医学院(郑州人民医院),河南郑州,450003
摘要:目的:探究继发性闭经患者采用补阳还五汤辨证加减治疗的效果。方法:选取在院的80例继发性闭经患者为研究对象,借助随机数字表法将选出的患者划分为研究组(n=40例)及对照组(n=40例)分别行常规西药+补阳还五汤辨证加减治疗与常规西药治疗。分析两组患者治疗效果及不良反应发生率。结果:研究组治疗有效性较高,为97.50%,高于对照组的70.00%(P<0.05)。研究组不良反应发生率为5.00%,低于对照组的20.00%(P<0.05)。治疗后,研究组降调查简表中各维度评分均高于对照组(P<0.05)。结论:继发性闭经患者采用补阳还五汤辨证加减治疗,可提升患者症状改善水平,保证治疗安全性,降低疾病对患者日常生活的影响,值得临床推广使用。
关健词:补阳还五汤;辨证加减;继发性闭经;疗效
Observation on the effect of Bu Yang Hui Wu Tang on secondary amenorrhea patients by means of syndrome differentiation and subtraction
Xiaohan Zhang
Department of Gynecology,the Fifth Clinical College of Henan University of Chinese Medicine/Zhengzhou People's Hospital,Zhengzhou 450003,China
Abstract:Purpose:To investigate the effect of Bu Yang Hui Wu Tang on secondary amenorrhea patients by means of syndrome differentiation and subtraction. Methods:Eighty cases of secondary amenorrhea inpatients were selected as research objects,and the selected patients were divided into a study group (n = 40) and a control group (n = 40) using a random number table method. The study group received routine western medicine + Bu Yang Hui Wu Tang syndrome differentiation and subtraction treatment,while the control group received routine western medicine treatment. The therapeutic effects and incidence of adverse reactions of the two groups were analyzed. Results:The study group had a higher effectiveness rate of 97.50%,which was higher than that of the control group at 70.00% (P < 0.05). The incidence of adverse reactions in the study group was 5.00%,lower than that of the control group at 20.00% (P < 0.05). After treatment,all dimensions of the SF-36 Health Survey scores in the study group were higher than those in the control group (P < 0.05). Conclusion:For secondary amenorrhea patients,the use of Bu Yang Hui Wu Tang with syndrome differentiation and subtraction can improve the level of symptom improvement,ensure treatment safety,reduce the impact of the disease on patients' daily life,and is worth promoting in clinical practice.
Keywords : Buyang huanwu decoction;Dialectical modified;Secondary amenorrhea;Curative effect

参考文献
[1] 王子莲.妇产科疾病临床诊断与治疗方案[M].北京:科学技术文献出版社,2010:447-452.
[2] 李致远,王文玲.继发性闭经的中西医治疗进展[J].中医研究,2013,26(1):78-80.
[3] 柯欢笑,王涵芝,赵宏利.运用“脾肾为本,风药为用”法治疗闭经体悟[J].浙江中医杂志,2024,59(5):444-445.
[4] 杨帆,谢亚莉.继发性闭经的病因病机及中医药治疗进展[J].辽宁中医药大学学报,2010,12(9): 211-213.
[5] 水凤凤,高迎巧.人流术后闭经中医研究进展[J].现代中西医结合杂志,2009,18(2):225-226.
[6] 葛菲茹,王香桂.王香桂主任医师治疗多囊卵巢综合征经验[J].浙江中医药大学学报,2008,32(4):450-451.
[7] 梁为生,闫永梅.调经丸治疗闭经 108 例[J].世界中医药,2009,4(1):38.
[8] 徐嵘.补肾活血胶囊治疗继发性闭经 56 例疗效观察[J].光明中医,2008,24(1):56-57.
[9] 曹文忠,刘明,庞文儒,等.针具针法组合提高继发性闭经疗效的临床研究[J].针灸临床杂志,2014,30(10):10-16.
[10] 赵润泽,李昕芹,王嘉琪,等.崔晓萍教授补肾益精法治疗继发性闭经[J].陕西中医药大学学报,2017,40(3):22-23.
论文收录证明 / 文献检索报告
Document Retrieval Certificate / Proof of Publication Indexing
作者贡献声明 / 贡献确认书
Author Contribution Statement / Certificate of Authorship Contribution
同行评审报告 / 评审意见
Peer Review Report / Peer Review Comments
利益冲突
Conflict of Interest
作者声明不存在任何利益冲突。
The author declares no conflict of interest.
版权声明
Copyright Statement
本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问: https://creativecommons.org/licenses/by/4.0/
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.
 
  Peer Review
同行评审
Editorial Services
编辑服务
Research Ethics Policy
研究伦理政策
Contributorship & Authorship
贡献者与署名
About Quest Press / Macau Sino Int. Med. Press
关于 Quest Press 与 Macau Sino Int. Med. Press
  Global Indexing
全球索引
Copyright Licensing
版权许可
Data Sharing Policy
数据共享政策
Appeal/Correction/Retraction
申诉/更正/撤回
  Online Submission
线上投稿
To the Librarian
致图书馆员
Open Access Statement
开放获取声明
Misconduct Handling Policy
处理不端行为政策
  Content Licensing
内容许可
Guidelines for Reviewers
审稿人指南
Quality Control Mechanism
质量把控机制
Academic Misconduct Screening Policy
学术不端筛查政策
  Advertising Policy
广告政策
Article Processing Charge (APC)
文章处理费
Publication Ethics Policy
出版伦理政策
Call for Editorial Board Members/Associate Editors/Peer Reviewers/Editors-in-Chief
诚邀编委、副主编、同行评审专家及主编